tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Agios Pharma (AGIO)
NASDAQ:AGIO
US Market
AGIO
Agios Pharma
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Agios Pharma (AGIO) Stock News & Sentiment

Compare
640 Followers
Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
Premium
Ratings
Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
1M ago
AGIO
Agios Pharma’s PYRUKYND Approved by Saudi Authority
Premium
Company Announcements
Agios Pharma’s PYRUKYND Approved by Saudi Authority
1M ago
8K
AGIO
Agios Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Agios Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
1M ago
AGIO
Agios Pharma’s Promising Growth: Buy Rating Backed by Strong Drug Performance and Strategic Focus
Premium
Ratings
Agios Pharma’s Promising Growth: Buy Rating Backed by Strong Drug Performance and Strategic Focus
1M ago
AGIO
Agios Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
Agios Pharmaceuticals Reports Q2 2025 Financial Results
1M ago
AGIO
Agios Pharma’s Strong Market Performance and Strategic Growth Prospects Drive Buy Rating
Premium
Ratings
Agios Pharma’s Strong Market Performance and Strategic Growth Prospects Drive Buy Rating
1M ago
AGIO
Agios Pharma’s Strategic Launch Preparations for Mitapivat and International Expansion
Premium
Ratings
Agios Pharma’s Strategic Launch Preparations for Mitapivat and International Expansion
1M ago
AGIO
More AGIO News >

AGIO News on the Web

AGIO Stock Falls as FDA Delays Decision on Pyrukynd for Thalassemia
Zacks
Bearish
Leerink Partners Keeps Their Hold Rating on Agios Pharma (AGIO)
TipRanks News
Neutral
TD Cowen Reaffirms Their Buy Rating on Agios Pharma (AGIO)
TipRanks News
Neutral
H.C. Wainwright still confident in approval of Agios' Pyrukynd despite delay
The Fly
Neutral
Why Agios Pharmaceuticals, Inc.’s (AGIO) Stock Is Down 16.33%
AAII
Neutral
Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?
Zacks
Neutral
Biotech Stocks Facing FDA Decision In September 2025
rttnews
Neutral
Agios Pharma (AGIO) Receives a Buy from Bank of America Securities
TipRanks News
Neutral

News Score - Last 7 Days

Negative
AGIO
Sector Average
Media Buzz
This Week7 articles
Weekly Average2.25 articles
News Sentiment
This Week0%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AGIO’s Media Buzz Sentiment?
7 articles about AGIO were published this week. In an average week, 2.25 articles are published.
    What is AGIO’s weekly average amount of articles?
    In an average week, 2.25 articles about AGIO are published.
      What is AGIO’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      HALOHalozyme
      UTHRUnited Therapeutics
      KNSAKiniksa Pharmaceuticals
      PHRPhreesia
      PNTGPennant Group
      Showing the stocks with the most bullish news sentiment over the past week

      Become an Expert with TipRanks Premium

      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis
      Subscribe NowSee Plans & Pricing